Dicerna Pharmaceuticals News Headlines (NASDAQ:DRNA)

$14.52
+0.09 (+0.62 %)
(As of 09/23/2019 04:52 AM ET)
Today's Range
$14.34
Now: $14.52
$14.68
50-Day Range
$12.77
MA: $13.91
$15.02
52-Week Range
$9.31
Now: $14.52
$17.07
Volume351,201 shs
Average Volume363,669 shs
Market Capitalization$992.59 million
P/E RatioN/A
Dividend YieldN/A
Beta2.23

Headlines

Dicerna Pharmaceuticals (NASDAQ DRNA) News Headlines

Source:
DateHeadline
Dicerna™ Appoints Patrick Gray to Board of Directors to Support Continued GrowthDicerna™ Appoints Patrick Gray to Board of Directors to Support Continued Growth
finance.yahoo.com - September 19 at 8:20 PM
How Should Investors Feel About Dicerna Pharmaceuticals, Inc.'s (NASDAQ:DRNA) CEO Pay?How Should Investors Feel About Dicerna Pharmaceuticals, Inc.'s (NASDAQ:DRNA) CEO Pay?
finance.yahoo.com - September 18 at 1:31 PM
Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) Expected to Announce Quarterly Sales of $11.70 MillionDicerna Pharmaceuticals Inc (NASDAQ:DRNA) Expected to Announce Quarterly Sales of $11.70 Million
www.americanbankingnews.com - September 12 at 5:57 AM
Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) Expected to Post Earnings of -$0.27 Per ShareDicerna Pharmaceuticals Inc (NASDAQ:DRNA) Expected to Post Earnings of -$0.27 Per Share
www.americanbankingnews.com - September 10 at 10:32 AM
Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) Given Average Recommendation of "Buy" by BrokeragesDicerna Pharmaceuticals Inc (NASDAQ:DRNA) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - September 4 at 2:53 PM
Dicerna™ to Present at H.C. Wainwright 21st Annual Global Investment ConferenceDicerna™ to Present at H.C. Wainwright 21st Annual Global Investment Conference
finance.yahoo.com - September 3 at 7:25 PM
3 Biopharma Stocks With Over 50% Upside3 Biopharma Stocks With Over 50% Upside
finance.yahoo.com - September 3 at 9:29 AM
BioBoyScout’s Online Biotech Valuation Calculators Help Small Investors See Value in Arrowhead Pharmaceuticals (ARWR)BioBoyScout’s Online Biotech Valuation Calculators Help Small Investors See Value in Arrowhead Pharmaceuticals (ARWR)
finance.yahoo.com - August 15 at 11:44 AM
Edited Transcript of DRNA earnings conference call or presentation 8-Aug-19 8:30pm GMTEdited Transcript of DRNA earnings conference call or presentation 8-Aug-19 8:30pm GMT
finance.yahoo.com - August 13 at 10:27 PM
Dicerna Pharmaceuticals Inc (DRNA) Q2 2019 Earnings Call TranscriptDicerna Pharmaceuticals Inc (DRNA) Q2 2019 Earnings Call Transcript
www.fool.com - August 9 at 9:58 PM
Dicerna Pharmaceuticals EPS misses by $0.04, misses on revenueDicerna Pharmaceuticals EPS misses by $0.04, misses on revenue
seekingalpha.com - August 9 at 12:48 AM
Dicerna™ Reports Second Quarter 2019 Financial Results and Provides Corporate UpdateDicerna™ Reports Second Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - August 9 at 12:47 AM
Dicerna™ to Report Second Quarter 2019 Financial Results and Host Conference Call on August 8, 2019Dicerna™ to Report Second Quarter 2019 Financial Results and Host Conference Call on August 8, 2019
finance.yahoo.com - August 1 at 11:42 PM
Dicernas DCR-PHXC a Breakthrough Therapy for rare kidney disorderDicerna's DCR-PHXC a Breakthrough Therapy for rare kidney disorder
seekingalpha.com - July 15 at 6:22 PM
Dicerna: An RNA Therapy-Based 21st Century Likely WinnerDicerna: An RNA Therapy-Based 21st Century Likely Winner
seekingalpha.com - July 12 at 8:48 AM
Dicerna to start clinical development of DCR-A1AT for liver diseaseDicerna to start clinical development of DCR-A1AT for liver disease
seekingalpha.com - July 2 at 8:52 AM
Dicerna™ to Begin Clinical Development of DCR-A1AT for Treatment of Patients with Alpha-1 Antitrypsin Deficiency-Associated Liver DiseaseDicerna™ to Begin Clinical Development of DCR-A1AT for Treatment of Patients with Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
finance.yahoo.com - July 2 at 8:52 AM
RNAi startup Dicerna developing new liver drugRNAi startup Dicerna developing new liver drug
finance.yahoo.com - July 2 at 8:52 AM
Dicerna reports additional data for DCR-PHXC in PH1 and PH2 patientsDicerna reports additional data for DCR-PHXC in PH1 and PH2 patients
seekingalpha.com - June 21 at 11:08 AM
Dicerna™ Presents Additional Data from PHYOX™1 Study of DCR-PHXC in Patients with Primary Hyperoxaluria Type 1 (PH1) and Type 2 (PH2)Dicerna™ Presents Additional Data from PHYOX™1 Study of DCR-PHXC in Patients with Primary Hyperoxaluria Type 1 (PH1) and Type 2 (PH2)
finance.yahoo.com - June 21 at 11:08 AM
Globally Recognized Nephrologist Joins Dicerna™ to Support Continued Development of DCR-PHXC for the Treatment of Primary HyperoxaluriaGlobally Recognized Nephrologist Joins Dicerna™ to Support Continued Development of DCR-PHXC for the Treatment of Primary Hyperoxaluria
finance.yahoo.com - June 20 at 8:24 AM
Did The Underlying Business Drive Dicerna Pharmaceuticalss (NASDAQ:DRNA) Lovely 393% Share Price Gain?Did The Underlying Business Drive Dicerna Pharmaceuticals's (NASDAQ:DRNA) Lovely 393% Share Price Gain?
finance.yahoo.com - June 18 at 3:51 PM
Did The Underlying Business Drive Dicerna Pharmaceuticals's (NASDAQ:DRNA) Lovely 393% Share Price Gain?Did The Underlying Business Drive Dicerna Pharmaceuticals's (NASDAQ:DRNA) Lovely 393% Share Price Gain?
finance.yahoo.com - June 18 at 3:51 PM
Dicerna™ Hires Industry Veterans to Lead Regulatory Affairs and Patient AdvocacyDicerna™ Hires Industry Veterans to Lead Regulatory Affairs and Patient Advocacy
finance.yahoo.com - June 13 at 8:20 AM
Bain's second life sciences fund comes in over $1 billionBain's second life sciences fund comes in over $1 billion
finance.yahoo.com - June 12 at 5:05 PM
Here’s What Hedge Funds Think About Dicerna Pharmaceuticals Inc (DRNA)Here’s What Hedge Funds Think About Dicerna Pharmaceuticals Inc (DRNA)
finance.yahoo.com - June 12 at 11:25 AM
Dicerna™ Appoints Rob Ciappenelli Chief Commercial OfficerDicerna™ Appoints Rob Ciappenelli Chief Commercial Officer
finance.yahoo.com - June 4 at 8:54 AM
Dicerna™ to Present at the Jefferies 2019 Healthcare ConferenceDicerna™ to Present at the Jefferies 2019 Healthcare Conference
finance.yahoo.com - May 28 at 5:56 PM
Dicerna begins patient dosing in early-stage HBV studyDicerna begins patient dosing in early-stage HBV study
seekingalpha.com - May 16 at 10:12 AM
Dicerna Announces Dosing of First Patient in Phase 1 Clinical Trial of DCR-HBVS for the Treatment of Chronic Hepatitis B VirusDicerna Announces Dosing of First Patient in Phase 1 Clinical Trial of DCR-HBVS for the Treatment of Chronic Hepatitis B Virus
finance.yahoo.com - May 16 at 10:11 AM
Dicerna Pharmaceuticals (DRNA) Reports Q1 Loss, Lags Revenue EstimatesDicerna Pharmaceuticals (DRNA) Reports Q1 Loss, Lags Revenue Estimates
finance.yahoo.com - May 10 at 8:54 AM
Edited Transcript of DRNA earnings conference call or presentation 9-May-19 8:30pm GMTEdited Transcript of DRNA earnings conference call or presentation 9-May-19 8:30pm GMT
finance.yahoo.com - May 10 at 8:54 AM
Dicerna Pharmaceuticals Inc (DRNA) Q1 2019 Earnings Call TranscriptDicerna Pharmaceuticals Inc (DRNA) Q1 2019 Earnings Call Transcript
www.fool.com - May 9 at 11:13 PM
Dicerna™ Reports First Quarter 2019 Financial and Operating Results and Provides Corporate UpdateDicerna™ Reports First Quarter 2019 Financial and Operating Results and Provides Corporate Update
www.businesswire.com - May 9 at 7:17 PM
Dicerna Pharmaceuticals misses by $0.16, misses on revenueDicerna Pharmaceuticals misses by $0.16, misses on revenue
seekingalpha.com - May 9 at 7:17 PM
Dicerna™ to Report First Quarter 2019 Financial Results and Host Conference Call on May 9, 2019Dicerna™ to Report First Quarter 2019 Financial Results and Host Conference Call on May 9, 2019
finance.yahoo.com - May 2 at 7:38 PM
Dicerna™ Submits Updated IND Application for DCR-PHXC for Treatment of Primary Hyperoxaluria (PH) for the PHYOX™2 Pivotal TrialDicerna™ Submits Updated IND Application for DCR-PHXC for Treatment of Primary Hyperoxaluria (PH) for the PHYOX™2 Pivotal Trial
finance.yahoo.com - May 2 at 8:55 AM
Dicerna™ to Present at the H.C. Wainwright Global Life Sciences ConferenceDicerna™ to Present at the H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - April 1 at 7:26 PM
Dicerna™ Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)Dicerna™ Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
finance.yahoo.com - April 1 at 7:26 PM
Dicerna reports updated data for DCR-PHXC in PH1 and PH2Dicerna reports updated data for DCR-PHXC in PH1 and PH2
seekingalpha.com - March 29 at 8:58 AM
Dicerna™ Announces the Presentation of Updated Data Demonstrating Utility of its Lead Compound DCR-PHXC in Treating Primary Hyperoxaluria Type 1 (PH1) and Type 2 (PH2)Dicerna™ Announces the Presentation of Updated Data Demonstrating Utility of its Lead Compound DCR-PHXC in Treating Primary Hyperoxaluria Type 1 (PH1) and Type 2 (PH2)
finance.yahoo.com - March 29 at 8:58 AM
Edited Transcript of DRNA earnings conference call or presentation 11-Mar-19 8:30pm GMTEdited Transcript of DRNA earnings conference call or presentation 11-Mar-19 8:30pm GMT
finance.yahoo.com - March 12 at 9:17 AM
Dicerna announces top 2019 milestones; shares down 2% after hoursDicerna announces top 2019 milestones; shares down 2% after hours
seekingalpha.com - March 11 at 7:14 PM
Dicerna™ Reports Fourth Quarter and Year Ended December 31, 2018 Financial Results and Provides Corporate UpdateDicerna™ Reports Fourth Quarter and Year Ended December 31, 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - March 11 at 7:13 PM
Dicerna Pharmaceuticals: 4Q Earnings SnapshotDicerna Pharmaceuticals: 4Q Earnings Snapshot
finance.yahoo.com - March 11 at 7:13 PM
Dicerna Pharmaceuticals (DRNA) Reports Q4 Loss, Lags Revenue EstimatesDicerna Pharmaceuticals (DRNA) Reports Q4 Loss, Lags Revenue Estimates
finance.yahoo.com - March 11 at 7:13 PM
New Research: Key Drivers of Growth for Energy Transfer LP, Domo, Accenture, Chevron, Cincinnati Financial, and Dicerna Pharmaceuticals — Factors of Influence, Major Initiatives and Sustained Production - GlobeNewswireNew Research: Key Drivers of Growth for Energy Transfer LP, Domo, Accenture, Chevron, Cincinnati Financial, and Dicerna Pharmaceuticals — Factors of Influence, Major Initiatives and Sustained Production - GlobeNewswire
globenewswire.com - March 6 at 7:02 PM
Dicerna to Report Fourth Quarter and Year End 2018 Financial Results and Host Conference Call on March 11, 2019Dicerna to Report Fourth Quarter and Year End 2018 Financial Results and Host Conference Call on March 11, 2019
finance.yahoo.com - March 4 at 7:24 PM
Dicerna Pharmaceuticals (DRNA) To Present At SVB Leerink 8th Global Healthcare Conference - Slideshow - Seeking AlphaDicerna Pharmaceuticals (DRNA) To Present At SVB Leerink 8th Global Healthcare Conference - Slideshow - Seeking Alpha
seekingalpha.com - March 3 at 8:33 AM
Dicerna Pharmaceuticals to Present at Upcoming Investor ConferencesDicerna Pharmaceuticals to Present at Upcoming Investor Conferences
finance.yahoo.com - February 22 at 6:41 PM
This page was last updated on 9/23/2019 by MarketBeat.com Staff

Featured Article: Margin

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel